Company Profile: JsureHealth was established in 2008 and headquartered in Shanghai. It is a leading innovative medical service enterprise in China. Focus on clinical research in China, provide quality services for medical institutions, pharmaceutical companies and doctors and patients, and establish offline and online integrated clinical support programs. 20 15 New Third Board was successfully listed. (Stock code: 834294) Gitzo Pharmaceutical Co., Ltd. provides innovative marketing services for pharmaceutical enterprises, helps excellent products to expand market share, and accelerates the listing cycle of new products. Provide innovative medical service assistance to medical institutions to help improve operational efficiency and service quality. Provide new product development opportunities at home and abroad for patients with diseases and provide the latest treatment plan. Provide pre-clinical research, clinical research patient recruitment, clinical research topic maintenance and clinical coordinator dispatch services. 20 14 provides patient management and education services, and Gitzo Health led the establishment of APRO (Asia-Pacific Patient Recruitment Alliance) on 20 15, and successfully listed the New Third Board. (Stock code: 834294)
Legal Representative: Ram Raymond.
Established: June 2008-1 1
Registered capital: 20 million yuan.
Industrial and commercial registration number: 310115001074185.
Type of enterprise: joint stock limited company (unlisted, invested or controlled by natural persons)
Company address: Room 2-A, Building 4, No.315, Guang Yuan West Road, Xuhui District, Shanghai.